2 Part Course  | 
Book places now

Valuing a Healthcare / Pharmaceutical Company

2 Part Course  |  Learn different, advanced techniques that can be utilised in assessing a pharmaceutical company’s value.

The delicate wings of a monarch butterfly on a pink flower

A one-day course presented over two-half days in a virtual class from 9:30am to 1:00pm UK time

Part One

Session 1

  • Defining the nuances of healthcare companies
    • Types of healthcare companies
      • Biotech
      • Pharmaceuticals
      • Medical Devices
      • Diagnostic tools
    • R&D and upfront spend
  • Handling unknows in healthcare valuations
    • Regulatory risk
    • Clinical trial risks
      • Patient enrolment
      • Finding the right end points
    • Risk adjustments
      • Using probabilities of success
    • Summary of valuation techniques which could be applied
      • DCF
      • Trading Comps
      • Transaction Comps
      • Cost of capital and discount rate
    • Considerations for valuing early stage clinical / biotechnology companies
      • Phases of drug development & Probability of Success
      • Patent life
      • Loss of exclusivity
  • Case study example of valuing a clinical (early) stage biotechnology company [On screen follow along exercise]

Session 2

Valuing start-up biotechnology company

  • Key clusters for start-up biotechnology companies
    • University spin-offs
    • Big Pharma R&D spin-offs
  • Lifecycle of biotech companies
    • Different stages of development and commercialisation
      • Discovery
      • Clinical development
      • Peak penetration
      • Loss of exclusivity
    • Clinical trials
      • What is key?
        • Efficacy profile
        • Safety profile
        • Regulatory labelling
      • Valuation issues
        • How to value know-how and R&D
        • Impact of cash burn
        • Estimating market size
        • Inherent problems of using the DCF model
        • Apply peak sales multiples
  • Case study example of valuing a start-up biotechnology company [On screen follow along exercise]
    • DCF derived valuation
    • Problems with peak-sales multiple analysis
    • Competitive dynamics
      • How do we know if we have the better product?
      • Mechanisms of action

Part Two

Session 1

  • A map of some of the key players in healthcare (Pharmaceuticals)
    • Major therapeutic areas in development
      • Oncology
      • Infectious diseases
      • Neurology
      • Haematology
      • Endocrinology
      • Respiratory
      • Dermatology
      • Cardiovascular
      • Psychiatry
      • Ophthalmology
      • Rheumatology
      • Others
    • Key pharmaceutical valuation drivers
      • Financials
      • M&A for brand / product acquisitions
        • Buy-and-build
        • Multiple arbitrage
      • Nature of commercialised products
        • OTC
        • Generics
        • Specialty Pharmaceuticals
      • Understanding the commercialisation strategy
        • Own sales force
        • Out licensed
        • Cost and margin impacts from commercialisation strategy
  • Case study example of a bolt on acquisition and using multiple arbitrage to create value [On screen follow along exercise] 

Session 2

  • Understand the peak revenue opportunity
    • Links to Epidemiology (disease prevalence and stratifying patient populations)
    • Peak penetration
    • Price per year
  • Building blocks for a pharmaceutical / biotech SOTP (Sum Of The Parts analysis)
    • DCF on a product-by-product basis
    • Other sources of tangible value (land, FDA priority review vouchers and others)
    • Allocation of central overhead costs
  • Case study example of valuing a commercial stage pharmaceutical company [On screen follow along exercise]
    • Royalty revenue streams and monetisation
      • What is royalty financing?
      • Emergent trends and TA focus areas for royalty financing
      • Key counterparties engaged in biopharma royalty financing
      • Types of licensing opportunities (horizontal vs vertical)
      • Tail and Cap provisions
  • Case study example of valuing a royalty consideration [On screen follow along exercise]

Our trainer is a highly accomplished professional with a track record of exceptional performance in various sell-side and buy-side roles. He began his career at Citigroup's Industrials team in London, where he gained extensive experience in M&A and capital markets activities. The trainer contributed to numerous pitches and transactions, specialising in diversified industrials, including automotive, aerospace & defence, and metals & mining sectors. Driven by his passion for US biotech investments, He joined Rothschild & Co. in a senior position, providing strategic financial advice to clients in the healthcare industry. His deep understanding of the sector enabled him to navigate complex challenges and identify lucrative opportunities.

Seeking to broaden his investing experience, the trainer entered portfolio management and investment analysis at Redline Capital Partners, focusing on long/short public equities. This allowed him to enhance his sector expertise and make informed investment decisions. In 2019, the trainer launched his own proprietary trading firm, Third Wave Capital, specialising in investments in US healthcare and technology sectors. Additionally, he has actively invested in Indian public equities and commodities for over a decade, collaborating with his family's investment endeavours.

Our trainer holds a Bachelor of Science (Hons) degree in Accounting & Finance from the University of Warwick, which has strengthened his financial knowledge and capabilities. With his wealth of experience and deep industry passion, He is highly regarded for his analytical skills, strategic thinking, and commitment to delivering exceptional results. He also provides training and consulting services to academic institutes and financial institutions, earning praise for his ability to deliver value to delegates with varying levels of experience.

  • Gain a thorough review of the practical valuation of pharmaceutical businesses.
  • Understand the nuances of valuing a healthcare company through practical examples and a review of different valuation techniques.

  • Delivered online to maximise the use of time.
  • Flexible in terms of delivery.
  • Understand the Pharmaceutical / Biotechnology valuation niche and the appropriate company valuation techniques.
  • Identify industry-specific metrics (Peak sales, patient population stratification, probability of success.)
  • Evaluate a range of valuation metrics for healthcare companies.
  • Practical examples of real Healthcare company valuation.

Our training programme is carried out using Zoom over 2 half days, but can also be delivered in modules over a longer period if required. The one-day valuing a healthcare company training programme has been designed to provide a comprehensive review of practical valuation techniques for healthcare businesses, this course focuses on assessing pharmaceutical companies and their specific valuation drivers. With extensive use of real-world examples, participants will gain hands-on experience in valuing healthcare companies, analysing industry metrics, and tackling valuation challenges.

  • The ‘Valuing a Healthcare / Pharmaceutical Company’ training was one of the most beneficial sessions I have ever attended. The lecturer, a top-notch industry professional, was exceptionally bright and knowledgeable. And he addressed all tricky questions passionately.
  • An abundance of brilliant materials provided.
  • I extend my gratitude to Redcliffe's team for selecting such top-talented lecturers, structuring materials perfectly, and organizing everything seamlessly.


Number of places:
Part 1

£ 695.00

Number of places:
Part 2

£ 695.00

Discounts available:
Virtual Class

  • 2 places at 30% less
  • 3 places at 40% less
  • 4 places at 50% less
  • 5 places at 55% less
  • 6+ places at 60% less
  • Select the number of course places and dates to automatically calculate the discount
    *T&Cs apply,
    click here
    to read
    Trusted By:

    We use cookies

    In order to show you courses tailored to your profession we use cookies.

    To enjoy all the features of this website please accept.